Activist 13D/13G Filings - Mereo BioPharma Group plc (MREO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-14
6:51 pm
Sale
13GMEREO BIOPHARMA GROUP PLC ADR
MREO
ORBIMED ADVISORS LLC0
0%
-10,378,591decrease
(Position Closed)
View
2024-02-14
2:11 pm
Unchanged
13GMEREO BIOPHARMA GROUP PLC ADR
MREO
Rock Springs Capital Management LP39,919,255
5.69%
0
(Unchanged)
View
2024-02-14
2:10 pm
Purchase
13GMEREO BIOPHARMA GROUP PLC ADR
MREO
Rock Springs Capital Management LP39,919,255
6.38%
8,694,770increase
(+27.85%)
View
2024-02-14
12:36 pm
Purchase
13GMEREO BIOPHARMA GROUP PLC ADR
MREO
MANGROVE PARTNERS IM LLC43,764,465
6.24%
43,764,465increase
(New Position)
View
2024-02-13
5:26 pm
Purchase
13GMEREO BIOPHARMA GROUP PLC ADR
MREO
SUVRETTA CAPITAL MANAGEMENT LLC36,854,190
5.3%
32,000increase
(+0.09%)
View
2024-02-06
4:15 pm
Purchase
13GMEREO BIOPHARMA GROUP PLC ADR
MREO
Soleus Private Equity Fund III L.P.48,887,095
7%
500,000increase
(+1.03%)
View
2024-02-05
5:09 pm
Purchase
13GMEREO BIOPHARMA GROUP PLC ADR
MREO
ADAGE CAPITAL PARTNERS GP L.L.C.50,250,000
7.17%
50,250,000increase
(New Position)
View
2023-11-20
08:45 am
Purchase
13DMEREO BIOPHARMA GROUP PLC ADR
MREO
Rubric Capital Management LP99,704,885
14.22%
2,378,330increase
(+2.44%)
View
2023-11-15
07:56 am
Purchase
13DMEREO BIOPHARMA GROUP PLC ADR
MREO
Rubric Capital Management LP97,326,555
13.88%
7,200increase
(+0.01%)
View
2023-11-13
07:31 am
Purchase
13DMEREO BIOPHARMA GROUP PLC ADR
MREO
Rubric Capital Management LP97,319,355
13.88%
1,758,195increase
(+1.84%)
View
2023-11-08
07:06 am
Purchase
13DMEREO BIOPHARMA GROUP PLC ADR
MREO
Rubric Capital Management LP95,561,160
13.63%
2,188,575increase
(+2.34%)
View
2023-11-06
07:30 am
Purchase
13DMEREO BIOPHARMA GROUP PLC ADR
MREO
Rubric Capital Management LP93,372,585
13.32%
1,081,380increase
(+1.17%)
View
2023-11-02
07:30 am
Purchase
13DMEREO BIOPHARMA GROUP PLC ADR
MREO
Rubric Capital Management LP92,291,205
13.25%
92,130increase
(+0.10%)
View
2023-10-30
6:02 pm
Purchase
13DMEREO BIOPHARMA GROUP PLC ADR
MREO
Rubric Capital Management LP92,199,075
13.15%
2,168,475increase
(+2.41%)
View
2023-08-10
4:42 pm
Sale
13GMEREO BIOPHARMA GROUP PLC ADR
MREO
BAKER BROS. ADVISORS LP14,604,391
2.2%
-54,754,968decrease
(-78.94%)
View
2023-07-26
4:31 pm
Purchase
13GMEREO BIOPHARMA GROUP PLC ADR
MREO
Soleus Private Equity Fund III L.P.48,387,095
7.5%
48,387,095increase
(New Position)
View
2023-06-16
08:00 am
Purchase
13DMEREO BIOPHARMA GROUP PLC ADR
MREO
Rubric Capital Management LP90,030,600
14.41%
6,250,000increase
(+7.46%)
View
2023-02-14
4:40 pm
Purchase
13GMEREO BIOPHARMA GROUP PLC ADR
MREO
ORBIMED ADVISORS LLC10,378,591
5.92%
4,315,246increase
(+71.17%)
View
2023-02-14
4:03 pm
Sale
13GMEREO BIOPHARMA GROUP PLC ADR
MREO
Point72 Asset Management L.P.22
0.1%
-10,609,978decrease
(-100.00%)
View
2023-02-14
4:00 pm
Purchase
13GMEREO BIOPHARMA GROUP PLC ADR
MREO
BAKER BROS. ADVISORS LP69,359,359
9.99%
4,441,758increase
(+6.84%)
View
Goto 0, 1, 2, Next